WO2009052209A3 - Isolation of stem cells and effective control of contamination - Google Patents

Isolation of stem cells and effective control of contamination Download PDF

Info

Publication number
WO2009052209A3
WO2009052209A3 PCT/US2008/080039 US2008080039W WO2009052209A3 WO 2009052209 A3 WO2009052209 A3 WO 2009052209A3 US 2008080039 W US2008080039 W US 2008080039W WO 2009052209 A3 WO2009052209 A3 WO 2009052209A3
Authority
WO
WIPO (PCT)
Prior art keywords
stem cells
isolation
contamination
effective control
relates
Prior art date
Application number
PCT/US2008/080039
Other languages
French (fr)
Other versions
WO2009052209A2 (en
Inventor
Kathy E Mitchell
Steven M Hoynowski
Original Assignee
Univ Kansas
Kathy E Mitchell
Steven M Hoynowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas, Kathy E Mitchell, Steven M Hoynowski filed Critical Univ Kansas
Publication of WO2009052209A2 publication Critical patent/WO2009052209A2/en
Publication of WO2009052209A3 publication Critical patent/WO2009052209A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The invention relates to the improved isolation and culture of stem cells. More particularly the invention relates to a method that provides for increased recovery of sterile and viable stem cells from umbilical cord and other tissue sources where stem cells are not readily dissociated.
PCT/US2008/080039 2007-10-16 2008-10-15 Isolation of stem cells and effective control of contamination WO2009052209A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98025207P 2007-10-16 2007-10-16
US60/980,252 2007-10-16

Publications (2)

Publication Number Publication Date
WO2009052209A2 WO2009052209A2 (en) 2009-04-23
WO2009052209A3 true WO2009052209A3 (en) 2009-08-13

Family

ID=40568060

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/080039 WO2009052209A2 (en) 2007-10-16 2008-10-15 Isolation of stem cells and effective control of contamination

Country Status (1)

Country Link
WO (1) WO2009052209A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248290A1 (en) * 2002-05-31 2004-12-09 Marco Riedel Culture systems for the sterile continuous cultivation of cells
US20050058631A1 (en) * 2003-06-27 2005-03-17 Kihm Anthony J. Postpartum cells derived from placental tissue, and methods of making and using the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248290A1 (en) * 2002-05-31 2004-12-09 Marco Riedel Culture systems for the sterile continuous cultivation of cells
US20050058631A1 (en) * 2003-06-27 2005-03-17 Kihm Anthony J. Postpartum cells derived from placental tissue, and methods of making and using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WEISS, M.L. ET AL.: "'Human Umbilibal Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease.'", STEM CELLS, vol. 24, 2006, pages 781 - 792 *

Also Published As

Publication number Publication date
WO2009052209A2 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
WO2008091908A3 (en) Human cancer stem cells
IL181340A0 (en) Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
TW201612312A (en) Meristematic plant cells and method of isolating them
AU2011372711B2 (en) Method for processing mesenchymal stem cells and the use thereof in the treatment of diseases associated with oxidative stress
EP1937326A4 (en) Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
WO2012019103A8 (en) System and apparatus for cell treatment
WO2010129441A3 (en) Method for separating stem cells from their more differentiated progeny using microfluidic devices
WO2009076559A8 (en) Secretion of fatty acids by photosynthetic microorganisms
MX348159B (en) Strain belonging to bacillus genus, microbiological agent, and plant cultivation method.
WO2010120757A3 (en) Regeneration of tissue without cell transplantation
WO2012006440A3 (en) Endothelial cell production by programming
WO2009038416A3 (en) Plant stem cell line derived from quiescent center and method for isolating the same
WO2010148334A3 (en) Generation of induced pluripotent stem cells from cord blood
WO2011038133A3 (en) Umbilical cord lining stem cells and methods and material for isolating and culturing same
EP3524672A3 (en) Reprogramming cancer cells
MX363238B (en) Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives.
MX2009004493A (en) Method for modifying plant architecture and enhancing plant biomass and/or sucrose yield.
WO2012087670A3 (en) Genetically engineered microorganisms comprising 4-hydroxybenzoyl-coa thioesterases and methods of using the same
WO2010104794A3 (en) Improved method for methane generation
MX2012004404A (en) Insecticidal fermentation broth from actinomycetes.
AU2022241885A1 (en) Methods for obtaining induced pluripotent stem cells
WO2013038269A3 (en) Apparatus and methods for treating sugarcane stem cuttings
WO2010011990A3 (en) Isolation of novel bacteria contributing to soilborne disease suppression
WO2009147179A3 (en) Process of producing male sterile monocotyledonous plants
EP2613800A4 (en) Maturation of gastrointestinal tract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08839100

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08839100

Country of ref document: EP

Kind code of ref document: A2